A PYMNTS Company

Australia: Court pulls Nurofen products from Australian market

By  |  December 14, 2015

he maker of the popular painkiller Nurofen was ordered on Monday to remove some of its brands from store shelves in Australia.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The Federal Court ruled that UK-based drug giant Reckitt Benckiser made misleading claims about the pills’ effectiveness.

    The court said Nurofen’s back pain, period pain, migraine pain, and tension headache brands were identical to standard Nurofen – despite being nearly double the price.

    Ruling on complaints made by the fair trading regulator, the Australian Competition and Consumer Commission, the court found all the products contained the same amount of the active ingredient: 342 milligrams of ibuprofen lysine.

    The drugs were “no more effective at treating the type of pain described on its packaging than any of the other Nurofen Specific Pain products”, the court ruled, according to an ACCC statement.

    Full content: Market Watch

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.